Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
974
NCT04519658
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 12, 2020
Completion: Jun 14, 2022
NCT05137002
A Study of CIN-107 in Patients With Uncontrolled Hypertension
Start: Dec 7, 2021
Completion: Oct 10, 2022
NCT06153420
Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
Start: Dec 28, 2023
Completion: Dec 9, 2025